Impact of FLT3 mutations and secondary cytogenetic changes on the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with a single agent arsenic trioxide regimen.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples